Anti-miR26b and anti-miR562 may prove to be efficient angiostatic agents to inhibit tumor angiogenesis, therefore curbing more advancement and metastasis
MDA-MB-231 cells are triple-negative and extremely aggressive breast cancer cells that categorical significant ranges of ANXA1 . We have shown that endogenous levels of miR26b and miR562 are reduced in…